NEW YORK(GenomeWeb) – Mass spec vendors turned in mixed third quarter results, but mass spec instrumentation itself showed solid growth, with particular strength in the North American academic and government markets.

The quarter also saw several new product announcements – in particular, products targeted at the clinical space, including AB Sciex's 4500MD Triple Quad and 4500MD QTRAP systems and a clinical system from Thermo Fisher Scientific consisting of the company's Prelude MD HPLC, Endura MD triple quadrupole, and ClinQuan MD software.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.